Clinical Trials on Locally Advanced Non Small Cell Lung Cancer (NSCLC) in United Kingdom
Total 3425 results
-
The Cooper Health SystemUnknownUntreated Advanced Non-Small Cell Lung CancerUnited States
-
Astellas Pharma IncCompletedNon-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyUnited Kingdom, United States, Brazil, Canada, Germany, Korea, Republic of, Poland, Romania, Russian Federation
-
Liza Villaruz, MDGenentech, Inc.CompletedAdvanced Non-small Cell Lung CancerUnited States
-
Prof Corinne Faivre-FinnRoyal Marsden NHS Foundation Trust; The Leeds Teaching Hospitals NHS Trust; Cambridge... and other collaboratorsCompletedNon Small Cell Lung CancerUnited Kingdom
-
howard safranThe Miriam Hospital; Rhode Island HospitalTerminatedNSCLC | Lung Cancer | Metastatic Lung Cancer | Non-small Cell Lung CancerUnited States
-
University College, LondonHoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerUnited Kingdom
-
Tesaro, Inc.Active, not recruitingNeoplasms | Solid Tumor | Non Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | Non Small Cell Lung Cancer Stage IIIB | Non Small Cell Lung Cancer MetastaticUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Locally Advanced Lung Non-Small... and other conditionsUnited States
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
Applied Spectral Imaging Ltd.CompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLS With Exon 20 Insertion MutationUnited States, Spain, Canada, Italy, Israel, Japan, United Kingdom, Korea, Republic of, Germany, France, Turkey, Belgium, Netherlands, Philippines, Poland, Singapore
-
Eli Lilly and CompanyCelgeneCompletedCarcinoma, Non-Small Cell Lung Cancer (NSCLC)United States
-
Ohio State University Comprehensive Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Locally Advanced Lung Non-Small...United States
-
NantCell, Inc.TerminatedAdvanced Squamous Non-Small Cell Lung CancerUnited States
-
Bridge Biotherapeutics, Inc.RecruitingEGFR Mutant Advanced Non-Small Cell Lung CancerKorea, Republic of, United States
-
National Cancer Institute (NCI)RecruitingAdvanced Non Small Cell Lung CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Australia, United States, Turkey, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of
-
AbbVieActive, not recruitingCancer | Advanced Solid Tumors | Metastatic Solid Tumors | Triple-Negative Breast Cancer (TNBC) | Non-small-cell-lung-cancer (NSCLC)United States, Australia, France, Israel, Spain, Taiwan
-
Erasca, Inc.CompletedAdvanced Non-squamous Non-small-cell Lung CancerUnited States
-
Bristol-Myers SquibbCompleted
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellUnited States, United Kingdom
-
Mirati Therapeutics Inc.TerminatedAdvanced Malignancies, Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC...United States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
Debiopharm International SASyneos HealthTerminatedNon-small Cell Lung CancerSpain, France, United Kingdom
-
Clovis Oncology, Inc.TerminatedLung Cancer | Solid Tumor | Non-small-cell Lung CancerUnited States, United Kingdom
-
Dynavax Technologies CorporationCompletedAdvanced Non Small Cell Lung CancerUnited States
-
OSI PharmaceuticalsCompletedAdvanced Non Small Cell Lung Cancer | Failed Prior ChemotherapyUnited States
-
AbbVieRecruitingNon Small Cell Lung CancerCanada, United Kingdom
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | EGFR Gene Mutation | Unresectable Lung Non-Small... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ROS1 Gene Rearrangement | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | ALK PositiveUnited States
-
University of California, San FranciscoAstraZenecaActive, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Cancer | Stage IB Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Cancer | Stage IIB Non-Small Cell Lung CancerUnited States
-
NYU Langone HealthWithdrawnAdvanced Non-small Cell Lung Cancer With KRAS G12C MutationUnited States
-
Nasser HannaGenentech, Inc.TerminatedNSCLC Stage IV | NSCLC, RecurrentUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedAdvanced Stage Non-small Cell Lung CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Taiwan, United States, Australia, Israel, Hong Kong, Chile, Korea, Republic of, Canada, Malaysia, Thailand
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Metastatic Lung Cancer | Advanced Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | Squamous Cell Lung CancerUnited States
-
Jeffrey ClarkeNovartis Pharmaceuticals; NantCell, Inc.CompletedAdvanced Solid Tumors, Non-small Cell Lung CancerUnited States
-
Stanford UniversityAstraZenecaRecruitingNon-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
Concordia Laboratories Inc.CompletedNon-small Cell Lung Cancer (NSCLC) | Lung MetastasisUnited States, Canada
-
Heather WakeleeEli Lilly and Company; Genentech, Inc.CompletedNeoplasm Metastasis | Lung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, France, Australia, Italy, Korea, Republic of, United Kingdom, Canada, Germany, Turkey, Hong Kong
-
University of LeedsUniversity College London Hospitals; The Leeds Teaching Hospitals NHS Trust; University... and other collaboratorsRecruitingNon Small Cell Lung CancerUnited Kingdom
-
Ariad PharmaceuticalsTakedaActive, not recruitingALK-positive Advanced NSCLCKorea, Republic of, United States, Spain, Taiwan, Canada, Hong Kong, China, Sweden, Australia, Italy, Japan, Germany, Netherlands, France, Austria
-
PfizerRecruitingNSCLC | Non-Small-Cell Lung CancerSpain, China, Taiwan, France, Singapore, Japan, United States
-
PfizerCompletedNon Small Cell Lung Cancer | Advanced Solid TumorsUnited States
-
TakedaActive, not recruitingALK+ Advanced NSCLCSpain, China, Korea, Republic of, Taiwan, Hong Kong, Thailand, Italy, Romania, United States, Mexico, Croatia, Russian Federation, Argentina, Canada, Germany, France, Austria, Chile, Greece, Sweden
-
University College, LondonBoehringer IngelheimCompletedNon-small Cell Lung CancerUnited Kingdom